Kim, C., Bu, F., Blacketer, C., Ostropolets, A., Duarte-Salles, T., Viernes, B., Falconer, T., Pistillo, A., Li, J., Yin, C., Zandt, M. V., Nagy, P., Nishimura, A., Minty, E., You, S. C., Sawano, M., Sawano, S., Jeon, J. Y., Aminorroaya, A., Dhingra, L. S., Pedroso, A. F., Thangaraj, P., Dorr, D. A., Pratt, N., Man, K. K. C., Lau, W. C. Y., Morales, D. R., Khera, R., Schuemie, M. J., Ryan, P. B., Hripcsak, G., Krumholz, H. M., Suchard, M. A., Lu, Y. (2026). Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes. Nature Communications. https://doi.org/10.1038/s41467-026-71307-0